Galid, Arik http://orcid.org/0000-0003-2740-8340
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 17 May 2020
Accepted: 17 June 2020
First Online: 1 September 2020
Conflict of interest
: A. Galid has received speaker’s fees and/or honoraria for consulting from Astra-Zeneca, Lilly, Novartis, Pfizer, Roche, Astra-Zeneca, Lilly, Novartis, Pfizer, Roche.